We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Report: Medtronic Misfiled More Than 1,000 Infuse Adverse Event Reports

(April 20, 2016, 8:52 AM EDT) -- MINNEAPOLIS — An internal study by Medtronic Inc. of off-label use of its Infuse bone graft found more than 1,000 adverse events but the company stopped the study and then misplaced...
To view the full article, register now.